+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Male Infertility Drug"

Infertility Treatment Global Market Report 2024 - Product Thumbnail Image

Infertility Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
From
Male Infertility - Pipeline Insights, 2022 - Product Thumbnail Image

Male Infertility - Pipeline Insights, 2022

  • Clinical Trials
  • November 2022
  • 50 Pages
  • Global
From
Male Infertility - Epidemiology Forecast - 2032 - Product Thumbnail Image

Male Infertility - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Male Infertility - Pipeline Review, H2 2020 - Product Thumbnail Image

Male Infertility - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 38 Pages
  • Global
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator

The Male Infertility Drug market is a subset of the Sexual and Reproductive Health Drugs market. It includes drugs used to treat male infertility, such as those used to increase sperm count, motility, and morphology. These drugs are typically prescribed to men who have difficulty conceiving due to low sperm count or poor sperm quality. They may also be used to treat conditions such as varicocele, which can cause infertility. In addition to drugs, the Male Infertility Drug market also includes other treatments such as assisted reproductive technologies (ARTs) and lifestyle modifications. ARTs include in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Lifestyle modifications may include dietary changes, exercise, and stress management. Some companies in the Male Infertility Drug market include Bayer AG, Merck & Co., Inc., Pfizer Inc., and Teva Pharmaceutical Industries Ltd. Show Less Read more